Gaskell, Elsie - Liverpool John Moores University - School of Pharmacy and Biomolecular Sciences

个人简介

Elsie Gaskell has been a member of teaching staff within the School of Pharmacy and Biomolecular Sciences since 2006. As a Senior Lecturer she is actively involved in the teaching and learning on two undergraduate programmes: Masters of Pharmacy (MPharm) and Applied Chemical and Pharmaceutical Sciences (ACAPS). She teaches across a number of different modules at each level of study. Elsie holds a PgCert HE (distinction) and is a Fellow of the Higher Education Academy. Elsie’s current administrative roles include leading a Level 7 MPharm module, Advanced Pharmaceutical Techniques and Delivery Systems (7001PDPHAR). In addition she is the module leader of the 120-credit Level 4 MPharm module, Integrated Foundations of Pharmacy (4000IMPHAR). She is also the Level 4 MPharm year leader. In 2015 she was awarded the Individual Teaching Award by the University. Elsie is a member of the Formulation and Drug Development (FDD) research group. Her current research interests are in the development of novel antimicrobial clay composites for wound care. Wound management with the aid of natural clay minerals has been documented. A new approach to wound management would be to design novel, synthetic antimicrobial materials related to the natural remedies. The work done within the FDD research group aims to investigate the properties of various synthetic clays alongside other natural clays, as well as to exploit their inherent ability to ion-exchange and intercalate clinically useful drug molecules to produce a bioinorganic hybrid drug delivery system.

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Gaskell EE, Hamilton AR. 2014. Antimicrobial clay-based materials for wound care FUTURE MEDICINAL CHEMISTRY, 6 :641-655 >DOI >Link Hamilton AR, Hutcheon GA, Roberts M, Gaskell EE. 2013. Formulation and antibacterial profiles of clay-ciprofloxacin composites Applied Clay Science, >DOI Gaskell EE, Evans A, Henney N, Penson P, Elliott PNC, Burrell H, Airley R, Ford W, Lane E, Allison GL. 2013. Therapeutics and Human Physiology Gaskell EE, Rostron C. OUP Oxford. Oxford, UK 9780199655298 Gaskell EE, Hamilton AR. 2014. Antimicrobial clay-based materials for wound care FUTURE MEDICINAL CHEMISTRY, 6 :641-655 >DOI >Link Tawfeek HM, Khidr SH, Samy EM, Ahmed SM, Gaskell EE, Hutcheon GA. 2014. Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery. Drug Dev Ind Pharm, 40 :1213-1222 >DOI >Link Hamilton AR, Hutcheon GA, Roberts M, Gaskell EE. 2013. Formulation and antibacterial profiles of clay-ciprofloxacin composites Applied Clay Science, >DOI Jan SU, Khan GM, Hussain I, Gaskell EE, Hutcheon GH. 2013. Synthesis, conjugation and evaluation of some novel polymers and their micro particles for sustained release drug formulations Pakistan Journal of Pharmaceutical Sciences, 26 :741-746 Gaskell EE, Sihanonth P, Rostron C, Hutcheon GA, Hobbs G. 2010. Isolation and identification of mucinolytic actinomycetes. Antonie Van Leeuwenhoek, 97 :211-220 >DOI >Link Gaskell EE, Hobbs G, Rostron C, Hutcheon GA. 2008. Encapsulation and release of alpha-chymotrypsin from poly(glycerol adipate-co-omega-pentadecalactone) microparticles. J Microencapsul, 25 :187-195 >DOI >Link Gaskell EE, Evans A, Henney N, Penson P, Elliott PNC, Burrell H, Airley R, Ford W, Lane E, Allison GL. 2013. Therapeutics and Human Physiology Gaskell EE, Rostron C. OUP Oxford. Oxford, UK 9780199655298 Tawfeek HM, Khidr SH, Samy EM, Ahmed SM, Evans A, Gaskell EE, Hutcheon GA. 2010. Encapsulation, release, bioactivity and cytotoxicity of lysozyme loaded poly(glycerol adipte-co-omega-pentadecalactone) microparticles JOURNAL OF PHARMACY AND PHARMACOLOGY, 62 :1431-1432 >Link McAllister L, Evans A, Hutcheon G, Gaskell E. 2009. Encapsulation of epirubicin for the treatment of cancer JOURNAL OF PHARMACY AND PHARMACOLOGY, 61 :A82-A82 >Link Iftikhar A, Gaskell E, Hutcheon GA, Rostron C. 2008. The stability of biodegradable polyesters and polyester-co-lactones utilized for drug delivery JOURNAL OF PHARMACY AND PHARMACOLOGY, 60 :A58-A58 >Link Hutcheon GA, Gaskell E, Iftikhar A, Rostron C. 2008. Overcoming the mucin barrier in the treatment of pulmonary cystic fibrosis JOURNAL OF PHARMACY AND PHARMACOLOGY, 60 :A11-A11 >Link Gaskell E, Hobbs G, Rostron C, Hutcheon GA. 2006. Encapsulation of mucinolytic enzymes for treatment of cystic fibrosis JOURNAL OF PHARMACY AND PHARMACOLOGY, 58 :A67-A67 >Link Gaskell E, Hobbs G, Rostron C, Hutcheon G. 2005. Use of functional polymers for treatment of pulmonary cystic fibrosis JOURNAL OF PHARMACY AND PHARMACOLOGY, 57 :S60-S60 >Link Gaskell E, Hobbs G, Rostron C, Hutcheon G. 2005. Use of functional polymers for treatment of pulmonary cystic fibrosis JOURNAL OF PHARMACY AND PHARMACOLOGY, 57 :S5-S5 >Link Hamilton AR, Roberts M, Hutcheon GA, Gaskell EE. Utilising montmorillonite K-10 and Laponite for delivery of ciprofloxacin UK & Ireland Controlled Release Society